معرفی
Dr. Vincent S. Gallicchio is a Professor in the Department of Biological Sciences at Clemson University’s College of Science. With 47 years in academic medicine and research, he specializes in stem cell biology, lithium applications, and drug pharmacology for AIDS/cancer. He has authored over 250 peer-reviewed publications, 36 book chapters, and secured $23M+ in research funding. His work includes 14+ patents and international recognition such as the Royal Society of Arts Fellowship and Queen Elizabeth II’s 2003 honor.
Education:
- PhD in Experimental Hematology, New York University, 1976
- Diploma in Medicine, University of Arad, 1986
- MT in Biomedical Laboratory Science, Yale University Hospital, 1971
- MS in Vertebrate Physiology, Southern CT State University, 1972
Research Focus: Stem cell therapies for degenerative conditions, lithium in non-psychiatric medicine, and preclinical drug development. Key areas include regenerative medicine, cancer pharmacology, and inflammation modulation.
Recent Trends in Publications: Over 15 articles since 2019 highlight stem cell applications in burn wounds, neurodegenerative diseases (e.g., Alzheimer’s), spinal cord injuries, and autism. Lithium’s role in inflammation and macrophage activity is a recurring theme, alongside pandemic impacts on medical education.
Awards:
- Queen Elizabeth II Recognition (2003)
- Special Issue Editor, Journal of Stem Cell Research (2021)
- NSF Grant Review Panelist (2020–2021)
- External Examiner for UTECH Hematology Program
Advising & Grants: Mentored students now active globally in medicine and research. Secured NSF and NIH grants, including leadership in the NIH/NICHD Contraceptive Clinical Trials Network review. Oversees $23M+ in funding from federal agencies and pharmaceutical partners.
Labs/Teams: Leads Clemson’s stem cell research initiatives and collaborates with UNESCO’s trace elements research network. Advises multiple student organizations like the American Medical Student Association and Pre-Dental Club.
